Vaxxinity Earnings Calls

Dec 31, 2025
Release date Mar 26, 2026
EPS estimate -
EPS actual -
Revenue estimate -
Revenue actual -
Jun 30, 2025
Release date May 12, 2026
EPS estimate -
EPS actual -
Revenue estimate -
Revenue actual -
Mar 30, 2025
Release date Jun 05, 2025
EPS estimate -
EPS actual -
Revenue estimate -
Revenue actual -
Dec 31, 2024
Release date Mar 27, 2025
EPS estimate -
EPS actual -
Revenue estimate -
Revenue actual -

Last 4 Quarters for Vaxxinity

Below you can see how VAXX performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.

Dec 31, 2024
Release date Mar 27, 2025
Price on release $0.0350
EPS estimate -
EPS actual -
Date Price
Mar 21, 2025 $0.0050
Mar 24, 2025 $0.0050
Mar 25, 2025 $0.0002
Mar 26, 2025 $0.0500
Mar 27, 2025 $0.0350
Mar 28, 2025 $0.0050
Mar 31, 2025 $0.0006
Apr 01, 2025 $0.0500
Apr 02, 2025 $0.0002
4 days before 600.00%
4 days after -99.43%
On release day 0%
Change in period -96.00%
Mar 30, 2025
Release date Jun 05, 2025
Price on release $0.0001
EPS estimate -
EPS actual -
Date Price
May 30, 2025 $0.0001
Jun 02, 2025 $0.0001
Jun 03, 2025 $0.0001
Jun 04, 2025 $0.0001
Jun 05, 2025 $0.0001
Jun 06, 2025 $0.0001
Jun 09, 2025 $0.0001
Jun 10, 2025 $0.0001
Jun 11, 2025 $0.0100
4 days before 0%
4 days after 9,900.00%
On release day 0%
Change in period 9,900.00%
Jun 30, 2025
Release date May 12, 2026
Price on release $0.0001
EPS estimate -
EPS actual -
Date Price
May 06, 2026 $0.0001
May 07, 2026 $0.0001
May 08, 2026 $0.0001
May 11, 2026 $0.0001
May 12, 2026 $0.0001
May 13, 2026 $0.0001
May 14, 2026 $0.0001
May 15, 2026 $0.0001
May 18, 2026 $0.0001
4 days before 0%
4 days after 0%
On release day 0%
Change in period 0%
Dec 31, 2025
Release date Mar 26, 2026
Price on release $0.0001
EPS estimate -
EPS actual -
Date Price
Mar 20, 2026 $0.0001
Mar 23, 2026 $0.0001
Mar 24, 2026 $0.0001
Mar 25, 2026 $0.0001
Mar 26, 2026 $0.0001
Mar 27, 2026 $0.0001
Mar 30, 2026 $0.0002
Mar 31, 2026 $0.0002
Apr 01, 2026 $0.0002
4 days before 0%
4 days after 100.00%
On release day 0%
Change in period 100.00%

Vaxxinity Earnings History

Earnings Calendar

FAQ

When is the earnings report for VAXX?
Vaxxinity, Inc. (VAXX) has scheduled its earnings report for Aug 12, 2026 after the markets close.

What is the VAXX price-to-earnings (P/E) ratio?
VAXX P/E ratio as of Jun 18, 2026 (TTM) is -0.222.

What is the VAXX EPS forecast?
The forecasted EPS (Earnings Per Share) for Vaxxinity, Inc. (VAXX) for the first fiscal quarter 2026 is -$0.120.

What are Vaxxinity, Inc.'s retained earnings?
On its balance sheet, Vaxxinity, Inc. reported retained earnings of $0 for the latest quarter ending Dec 31, 2025.

What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.

Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.

What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
Click to get the best stock tips daily for free!
ABOUT VAXXINITY, INC.
Vaxxinity
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that targets toxic forms of aggregated a-synuclein in the brain to fight Parkinson's disease and other synu...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
7.76% Jun 12
DHI
$146.71
7.57% Jun 10
PHM
$118.49
7.15% Jun 10
EAT
$140.46
17.39% Jun 05
TPR
$140.47
2.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE